ABG
FRLN

Ally Bridge Group’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Ally Bridge Group’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-26,783
Closed -$3.27M – 37
2021
Q2 		$3.27M Sell
26,783
-465
-2% -$72.3K 0.81% 28
2021
Q1 		$5.03M Sell
27,248
-1,085
-4% -$257K 0.96% 28
2020
Q4 		$7.76M Buy
+28,333
New +$7.12M 1.33% 21

Other funds holding FRLN

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Ally Bridge Group's FRLN Position: Q3 2021 in Review

Ally Bridge Group sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q3 2021, closing a stake of 26,783 shares — an estimated $3.27M sold.

Ally Bridge Group first reported a position in FRLN in Q4 2020 and held it in 3 quarters. The position peaked at $7.76M in Q4 2020. 20 funds tracked by Wall St. Rank hold FRLN as of Q3 2021.

  • Ally Bridge Group reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Ally Bridge Group sold 26,783 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q3 2021, an estimated $3.27M.
  • Ally Bridge Group first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q4 2020 and held it in 3 quarters.
  • Ally Bridge Group's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $7.76M in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q3 2021.

Based on Ally Bridge Group's 13F filing for Q3 2021, filed 15 Nov 2021.